SAINTE CATHERINE, INSTITUT DU CANCER AVIGNON-PROVENCE

What SAINTE CATHERINE, INSTITUT DU CANCER AVIGNON-PROVENCE does

SAINTE CATHERINE, Institut du Cancer Avignon-Provence (ICAP) is a French non-profit oncology center founded in 1946 by Dr. Georges Reboul in Avignon, operating as a private health establishment of collective interest (ESPIC) admitted to the French Public Hospital Service since 2001 and affiliated with the UNICANCER network since April 2021. The institute provides comprehensive cancer care from prevention through treatment to palliative care and after-cancer follow-up, structured around seven organ-based Functional Units (Onco digestif, Onco thoracique, Onco ORL-neuro, Onco Sein-Gynéco, Onco Urologie, Onco hématologie-mélanomes-sarcomes, Onco soins de support) plus dedicated research and teaching structures.

The institute operates 74 conventional hospitalization beds, 15 week hospitalization beds, 59 ambulatory places, and a 54-chair day hospital on its 250 Chemin de Baigne-pieds campus. Its radiotherapy department houses 7 linear accelerators (including the Halcyon 5.0, the first deployed in Europe in December 2025) and delivered 51,000 sessions in the most recent year, while the chemotherapy unit delivered 24,000 sessions and 38,500 medical consultations were conducted. A 1,320 m² medical imaging platform, on-site BIOAXIOME molecular biology laboratory (COFRAC-accredited since 2004), and the My Web ISC patient portal comprise the core technical infrastructure. In 2024, the institute served 21,500 patients including 3,100 new patients, with approximately 10,000 mammographies performed across the Vaucluse, Bouches-du-Rhône, Gard, and Drôme Ardèche organized screening programs.

ICAP generates revenue primarily through French Social Security reimbursement under tariffs set by prefectural decree, with long-term disease (ALD) treatments covered at 100%. Supplementary revenue comes from patient stay fees (a daily flat rate of 20 euros as of January 2019), private room supplements, and ancillary services (TV, telephone, WiFi, companion meals). The institute's 2026-2030 strategic project reaffirms its non-profit model, supported by 7 to 8 organizational pillars including an active prevention program (Interception), a Tobacco-Free Health Site initiative, and clinical research operations certified ISO 9001 since November 2018.

Name

SAINTE CATHERINE, INSTITUT DU CANCER AVIGNON-PROVENCE

Legal name

SAINTE CATHERINE, INSTITUT DU CANCER AVIGNON-PROVENCE

Website

https://icap84.org

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

101–250 employees

Short description

SAINTE CATHERINE, Institut du Cancer Avignon-Provence (ICAP) is a French non-profit oncology center founded in 1946, serving 21,500 patients annually across seven organ-based cancer units in the PACA region through radiotherapy, chemotherapy, imaging, and supportive care.

Ownership category

akta.pro rank

Product category

Oncology and Cancer Treatment Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Oncology treatment services
• Cancer radiotherapy
• Chemotherapy administration
• Cancer screening imaging
• Palliative care

Headquarters

HQ city

Avignon

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Public Healthcare Reimbursement: As a private not-for-profit health establishment of collective interest (ESPIC), Sainte-Catherine operates under the French social security system. All care tariffs are strictly those set by the Social Security convention based on a prefectural decree. Long-term disease (ALD) treatments are covered at 100%. The establishment's non-profit model is reaffirmed in its 2026-2030 strategic project.
2. Patient Stay Fees and Supplementary Services: Patients pay a daily flat rate (forfait journalier) of 20 euros per day as of January 2019, which contributes to accommodation and maintenance costs. Private room supplements and optional services (TV, telephone, WiFi) are billed as complementary services. Accompanying meal services are also available for a fee.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

SAINTE CATHERINE, Institut du Cancer Avignon-Provence (ICAP) is a private non-profit cancer center providing comprehensive oncology services including radiotherapy (7 accelerators), chemotherapy (24,000 sessions/year), medical imaging (mammography, MRI, CT, ultrasound), palliative care, supportive care, and clinical research. The institute operates through 7 organ-based functional units (digestive, thoracic, breast-gyneco, urology, ORL-neuro, hematology-melanoma-sarcoma, supportive care) and serves 21,500 patients annually across the PACA region of France.

Product overview

SAINTE CATHERINE, Institut du Cancer Avignon-Provence is a cancer care institute offering an integrated, multi-service platform centered on oncology treatment and prevention. The core portfolio spans radiotherapy (7 accelerators, 51,000 sessions/year), chemotherapy (24,000 sessions/year), medical imaging (1,320 m² technical platform), and organ-specific oncology functional units (digestive, thoracic, ORL, breast-gyneco, urology, hematology). Patient-facing digital services include My Web ISC, a secure portal for care program access and appointment management. Specialized programs include the Interception cancer prevention initiative and Tobacco-Free Health Facility certification. The institute operates 74 conventional beds, 59 ambulatory places, and a 54-chair day hospital, serving 21,500 patients annually including 3,100 new patients.

Differentiator

Problem solved

Functional benefit

Brands

• My Web ISC: Interactive and secure web platform facilitating the link between patients and healthcare professionals in the care pathway, containing medical records, personalized care programs, appointments, and medical reports.
• Interception
• Lieu de Santé Sans Tabac (LSST)
• Maison Sainte Catherine
• SOS Sein

Products and services

• My Web ISC Patient Portal

Quantifiable outcome

• Nearly 10,000 mammographies performed annually; approximately 6% of breast cancers detected each year in the organized screening program are identified through mandatory second reading by an experienced radiologist
• +4 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature4 records

Partnerships

15 partnerships are on record, tiered core, major and minor.

• UNICANCER PACA Charter (Centre Antoine Lacassagne, Nice & Institut Paoli-Calmettes, Marseille)coreStrategic or Co-development Partner · 1 September 2023In September 2023, Sainte-Catherine (Avignon), Centre Antoine Lacassagne (Nice), and Institut Paoli-Calmettes (Marseille) signed the UNICANCER PACA charter, demonstrating a strong commitment to fighting cancer in the Sud Region. The three institutions committed to collaborative work to leverage each institution's expertise, diffuse therapeutic, technological, and organizational advances in oncology, strengthen visibility, and carry a shared project.
• UNICANCERcoreStrategic or Co-development Partner · 8 April 2021Sainte-Catherine became an affiliated member of UNICANCER (GCS - Groupement de coopération sanitaire) on April 8, 2021. UNICANCER is the only French hospital network 100% dedicated to cancer care, grouping 18 French Cancer Centers across 20 hospital sites. UNICANCER provides Sainte-Catherine with access to shared clinical trials, best practices, collective expertise, and innovation within the network. It is also the leading academic promoter of clinical trials in oncology in Europe.
• ONCOPACA-Corse (Réseau Régional de Cancérologie)coreStrategic or Co-development PartnerSainte-Catherine is a signatory of a cooperation convention with the ONCOPACA-Corse Regional Cancer Network, which promotes and improves the quality of patient care under the Cancer Plan. The network groups public and private healthcare establishments and liberal health professionals from PACA and Corsica regions and Monaco. It coordinates Réunions de Concertation Pluridisciplinaires (RCP) and maintains a regional database of cancer cases.
• Centre Hospitalier d'AvignoncoreStrategic or Co-development PartnerThe Centre Hospitalier d'Avignon is the support establishment of the GHT (Groupement Hospitalier de Territoire) of Vaucluse, which includes 11 healthcare facilities. Sainte-Catherine collaborates with the CH Avignon through the 3C (Centre de Coordination en Cancérologie) and shared RCPs. The CH Avignon also partners with ICAP on the Lieu de Santé Sans Tabac (LSST) initiative.
• Institut Paoli-Calmettes (IPC), MarseillemajorStrategic or Co-development PartnerIPC is a Cancer Control Center, member of the Unicancer group, governed by the French Public Health Code. It is a member of the Onco Paca Corse Cancerology Network. As part of the UNICANCER PACA charter, IPC collaborates with Sainte-Catherine on sharing therapeutic, technological, and organizational advances in oncology.
• Centre Antoine Lacassagne (CAL), NicemajorStrategic or Co-development PartnerCAL is a Cancer Control Center and member of the Unicancer group. As part of the UNICANCER PACA charter, CAL collaborates with Sainte-Catherine on sharing therapeutic, technological, and organizational advances in oncology. CAL also partners on the Lieu de Santé Sans Tabac (LSST) initiative.
• BIOAXIOME (Medical Biology Laboratory)coreTechnology or IntegrationA molecular biology analysis laboratory present on the Sainte-Catherine campus, connected directly to ICAP to facilitate patient care. Provides routine analyses and molecular biology analyses for personalized cancer treatments. COFRAC accredited since 2004. Open to all external patients. Hours: Mon-Thu 7:30-18:30, Fri 7:30-17:30.
• Gustave RoussymajorStrategic or Co-development PartnerGustave Roussy developed the Interception program for personalized cancer prevention and early detection for high-risk individuals. Sainte-Catherine has committed to implementing this program since 2024, including two initial care pathways for heavy smokers over 50 and women with significant family history of breast cancer without known genetic mutations.
• ARS PACA (Agence Régionale de la Santé PACA)majorStrategic or Co-development PartnerARS PACA launched the 'Lieu de Santé Sans Tabac' (LSST) call for projects, piloted by RESPADD (Réseau de Prévention des Addictions). ICAP responded to the call and is pursuing Silver-level certification for its tobacco-free health facility initiative.
• RESPADD (Réseau de Prévention des Addictions)majorStrategic or Co-development PartnerRESPADD pilots the Lieu de Santé Sans Tabac (LSST) certification program. ICAP collaborates with RESPADD on the LSST initiative, implementing 8 certification norms for tobacco-free healthcare facilities.
• Provence Stomie ContactminorStrategic or Co-development PartnerPartnership signed April 7 with the association Provence Stomie Contact (founded 2007, chaired by Dr Laurent MINEUR) to provide support for patients with digestive or urinary stomies and their caregivers. Includes pre- and post-operative education, psychological support, and daily life assistance. Coordinated by ICAP's stomatherapist nurse and the Oncological Support Unit.
• ELSANminorChannel Partner/ Reseller/ DistributorELSAN is a private healthcare group referenced in connection with the Clinique Rhône-Durance on the Sainte-Catherine campus site. The nature of the partnership is not detailed on the ICAP website.
• Institut du Cancer de Montpellier (ICM)minorStrategic or Co-development PartnerFounded in 1923, ICM is one of the oldest Cancer Control Centers in France, member of the Unicancer group. Located in eastern Occitanie, ICM shares expertise and collaborates with Sainte-Catherine within the Unicancer network.
• Patient Support Associations (Ligue contre le Cancer 84, Europa Donna, Vivre comme avant, L'Autre Rive, Regain, Jalmalv)minorStrategic or Co-development PartnerMultiple associations present at Sainte-Catherine providing patient support: Ligue contre le Cancer 84 (financial support, solidarity actions, prevention), Europa Donna (breast cancer patient association), Vivre comme avant (breast cancer moral support), and palliative care associations L'Autre Rive, Regain, and Jalmalv (volunteer support 7 days/week, 14h-17h). Ligue 84 also provides art therapy and music therapy at the Maison Sainte-Catherine.
• C2DS (Comité Développement Durable en Santé)minorStrategic or Co-development PartnerSince 2015, Sainte-Catherine has been a member of C2DS, an association of more than 500 health organizations committed to Sustainable Development. C2DS provides regulatory monitoring, indicators, training, and best practice sharing related to environmental obligations.

Scale indicators15 records

Recent moves13 records

Expansion highlights6 records

Direct peers

• Institut du Cancer de Montpellier (ICM): One of the oldest French Cancer Control Centers, founded in 1923, member of UNICANCER. Same integrated oncology platform and shares expertise with Sainte-Catherine within the UNICANCER network.
• Centre Jean Perrin: UNICANCER Cancer Center in Clermont-Ferrand offering integrated oncology care comparable to Sainte-Catherine's model, including organ-based organization and clinical research.
• Centre Antoine Lacassagne (CAL): Cancer Control Center in Nice, member of UNICANCER, and co-signatory of the 2023 UNICANCER PACA charter alongside Sainte-Catherine and IPC. Same integrated cancer-care model and similar position as a regional referral center.
• Institut Paoli-Calmettes (IPC): Comprehensive Cancer Center in Marseille, member of UNICANCER and co-signatory of the 2023 UNICANCER PACA charter with Sainte-Catherine. Provides the same integrated oncology model (radiotherapy, chemotherapy, organ-based functional units, clinical research) and is the primary regional peer in PACA.
• Centre François Baclesse: UNICANCER Comprehensive Cancer Center in Caen (Normandy) with the same integrated cancer-care platform: radiotherapy, chemotherapy, organ-specific units, palliative care, and clinical research.
• Institut Bergonié: UNICANCER Comprehensive Cancer Center in Bordeaux with integrated oncology services across radiotherapy, chemotherapy, surgery, and clinical research. Directly comparable institutional model.
• Centre Léon Bérard: UNICANCER Comprehensive Cancer Center in Lyon with the same integrated oncology care model (radiotherapy, chemotherapy, organ-based units, palliative care) and similar institutional position as a regional referral center.
• Institut de Cancérologie de l'Ouest (ICO): UNICANCER-affiliated cancer center with sites in Angers and Nantes. Operates the same model of integrated oncology care, clinical research, and screening programs as Sainte-Catherine.

Broad incumbents

• Gustave Roussy: Leading European cancer center and UNICANCER member, headquartered in Villejuif. Steward of the Interception program that Sainte-Catherine has implemented; a broader incumbent with much larger scale than ICAP.
• Institut Curie: Historic Paris-based cancer research and treatment center combining hospital and research center. Operates a comparable integrated oncology model with strong radiotherapy and clinical research capabilities.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/institut-sainte-catherine

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SAINTE CATHERINE, INSTITUT DU CANCER AVIGNON-PROVENCE